Insider · CIK 0002042690
Ivan Cheung
Files at LXRX (LEXICON PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Ivan Cheung files SEC Form 4 as director at LXRX (LEXICON PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ivan Cheung has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +89,312 | $0.00 | $0 | 89,312 | Jun 4, 2026 |
| Jun 3, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -89,312 | $0.00 | $0 | 0 | Jun 4, 2026 |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +35,714 | $0.00 | $0 | 35,714 | May 4, 2026 |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +43,478 | $0.00 | $0 | 43,478 | May 4, 2026 |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +103,806 | $0.00 | $0 | 103,806 | Jun 3, 2025 |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +89,312 | $0.00 | $0 | 89,312 | Jun 3, 2025 |
| Dec 2, 2024 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +186,685 | $0.00 | $0 | 186,685 | Dec 2, 2024 |
Questions about Ivan Cheung
Answered from the filings on this page, as of the latest one.
Is Ivan Cheung buying or selling?
Ivan Cheung has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ivan Cheung's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ivan Cheung has 0.
Where does Ivan Cheung file Form 4?
Ivan Cheung has filed Form 4 at LXRX (LEXICON PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.